FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322491068> ?p ?o ?g. }

• W4322491068 endingPage "109882" @default.
• W4322491068 startingPage "109882" @default.
• W4322491068 abstract "Immunotherapy is an additional pillar when combined with traditional standards of care such as chemotherapy, radiotherapy, and surgery for cancer patients. It has revolutionized cancer treatment and rejuvenated the field of tumor immunology. Several types of immunotherapies, including adoptive cellular therapy (ACT) and checkpoint inhibitors (CPIs), can induce durable clinical responses. However, their efficacies vary, and only subsets of cancer patients benefit from their use. In this review, we address three goals: to provide insight into the history of these approaches, broaden our understanding of immune interventions, and discuss current and future approaches. We highlight how cancer immunotherapy has evolved and discuss how personalization of immune intervention may address present limitations. Cancer immunotherapy is considered a recent medical achievement and in 2013 was selected as the “Breakthrough of the Year” by Science. While the breadth of immunotherapeutics has been rapidly expanding, to include the use of chimeric antigen receptor (CAR) T-cell therapy and immune checkpoint inhibitor (ICI) therapy, immunotherapy dates back over 3000 years. The expansive history of immunotherapy, and related observations, have resulted in several approved immune therapeutics beyond the recent emphasis on CAR-T and ICI therapies. In addition to other classical forms of immune intervention, including human papillomavirus (HPV), hepatitis B, and the Mycobacterium bovis Bacillus Calmette-Guérin (BCG) tuberculosis vaccines, immunotherapies have had a broad and durable impact on cancer therapy and prevention. One classic example of immunotherapy was identified in 1976 with the use of intravesical administration of BCG in patients with bladder cancer; resulting in a 70 % eradication rate and is now standard of care. However, a greater impact from the use of immunotherapy is documented by the prevention of HPV infections that are responsible for 98 % of cervical cancer cases. In 2020, the World Health Organization (WHO) estimated that 341,831 women died from cervical cancer [1]. However, administration of a single dose of a bivalent HPV vaccine was shown to be 97.5 % effective in preventing HPV infections. These vaccines not only prevent cervical squamous cell carcinoma and adenocarcinoma, but also oropharyngeal, anal, vulvar, vaginal, and penile squamous cell carcinomas. The breadth, response and durability of these vaccines can be contrasted with CAR-T-cell therapies, which have significant barriers to their widespread use including logistics, manufacturing limitations, toxicity concerns, financial burden and lasting remissions observed in only 30 to 40 % of responding patients. Another, recent immunotherapy focus are ICIs. ICIs are a class of antibodies that can increase the immune responses against cancer cells in patients. However, ICIs are only effective against tumors with a high mutational burden and are associated with a broad spectrum of toxicities requiring interruption of administration and/or administration corticosteroids; both of which limit immune therapy. In summary, immune therapeutics have a broad impact worldwide, utilizing numerous mechanisms of action and when considered in their totality are more effective against a broader range of tumors than initially considered. These new cancer interventions have tremendous potential notability when multiple mechanisms of immune intervention are combined as well as with standard of care modalities." @default.
• W4322491068 created "2023-02-28" @default.
• W4322491068 creator A5024894397 @default.
• W4322491068 creator A5086538924 @default.
• W4322491068 creator A5089092786 @default.
• W4322491068 date "2023-04-01" @default.
• W4322491068 modified "2023-10-17" @default.
• W4322491068 title "Highlights into historical and current immune interventions for cancer" @default.
• W4322491068 cites W1187022970 @default.
• W4322491068 cites W1217937522 @default.
• W4322491068 cites W126775936 @default.
• W4322491068 cites W146717125 @default.
• W4322491068 cites W1483194800 @default.
• W4322491068 cites W1510772693 @default.
• W4322491068 cites W1514881244 @default.
• W4322491068 cites W1516590180 @default.
• W4322491068 cites W1519295343 @default.
• W4322491068 cites W1528911741 @default.
• W4322491068 cites W1553013513 @default.
• W4322491068 cites W1568406709 @default.
• W4322491068 cites W1577406904 @default.
• W4322491068 cites W1590191111 @default.
• W4322491068 cites W1592924232 @default.
• W4322491068 cites W1611944043 @default.
• W4322491068 cites W1642873092 @default.
• W4322491068 cites W1688526230 @default.
• W4322491068 cites W176965263 @default.
• W4322491068 cites W1823658262 @default.
• W4322491068 cites W1828940258 @default.
• W4322491068 cites W1883933571 @default.
• W4322491068 cites W188630774 @default.
• W4322491068 cites W1889143162 @default.
• W4322491068 cites W1907513513 @default.
• W4322491068 cites W1942950379 @default.
• W4322491068 cites W1965979673 @default.
• W4322491068 cites W1972776583 @default.
• W4322491068 cites W1977131802 @default.
• W4322491068 cites W1979275399 @default.
• W4322491068 cites W1979461469 @default.
• W4322491068 cites W1980292049 @default.
• W4322491068 cites W1984768954 @default.
• W4322491068 cites W1984794796 @default.
• W4322491068 cites W1992249154 @default.
• W4322491068 cites W1993940563 @default.
• W4322491068 cites W1996136370 @default.
• W4322491068 cites W1997353354 @default.
• W4322491068 cites W1998708842 @default.
• W4322491068 cites W2001376776 @default.
• W4322491068 cites W2004751790 @default.
• W4322491068 cites W2005354199 @default.
• W4322491068 cites W2010205433 @default.
• W4322491068 cites W2010222949 @default.
• W4322491068 cites W2011868916 @default.
• W4322491068 cites W2012913493 @default.
• W4322491068 cites W2013177587 @default.
• W4322491068 cites W2016840392 @default.
• W4322491068 cites W2021801896 @default.
• W4322491068 cites W2023003954 @default.
• W4322491068 cites W2023298664 @default.
• W4322491068 cites W2023702014 @default.
• W4322491068 cites W2025369483 @default.
• W4322491068 cites W2028460943 @default.
• W4322491068 cites W2030839365 @default.
• W4322491068 cites W2032407590 @default.
• W4322491068 cites W2034551415 @default.
• W4322491068 cites W2036631709 @default.
• W4322491068 cites W2036999053 @default.
• W4322491068 cites W2037602993 @default.
• W4322491068 cites W2037827983 @default.
• W4322491068 cites W2039332929 @default.
• W4322491068 cites W2039377507 @default.
• W4322491068 cites W2041656718 @default.
• W4322491068 cites W2042662562 @default.
• W4322491068 cites W2044255565 @default.
• W4322491068 cites W2046972425 @default.
• W4322491068 cites W2047008207 @default.
• W4322491068 cites W2047205338 @default.
• W4322491068 cites W2047367828 @default.
• W4322491068 cites W2047988170 @default.
• W4322491068 cites W2050457398 @default.
• W4322491068 cites W2051636382 @default.
• W4322491068 cites W2051962533 @default.
• W4322491068 cites W2053463299 @default.
• W4322491068 cites W2054947389 @default.
• W4322491068 cites W2058331779 @default.
• W4322491068 cites W2059453959 @default.
• W4322491068 cites W2060206902 @default.
• W4322491068 cites W2060926084 @default.
• W4322491068 cites W2061249548 @default.
• W4322491068 cites W2064006160 @default.
• W4322491068 cites W2067480394 @default.
• W4322491068 cites W2072701861 @default.
• W4322491068 cites W2079708811 @default.
• W4322491068 cites W2085530853 @default.
• W4322491068 cites W2087680655 @default.
• W4322491068 cites W2088916508 @default.
• W4322491068 cites W2089828715 @default.
• W4322491068 cites W2094652659 @default.

• next